Lang NN - Search Results

1

Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans.

Japp AG, Chelliah R, Tattersall L, Lang NN, Meng X, Weisel K, Katz A, Burt D, Fox KA, Feuerstein GZ, Connolly TM, Newby DE. Japp AG, et al. Among authors: lang nn. J Am Heart Assoc. 2013 Jan 28;2(1):e006007. doi: 10.1161/JAHA.112.006007. J Am Heart Assoc. 2013. PMID: 23525448 Free PMC article. Clinical Trial.

2

Connexin 43 mediates endothelium-derived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women.

Lang NN, Luksha L, Newby DE, Kublickiene K. Lang NN, et al. Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1026-32. doi: 10.1152/ajpheart.00797.2006. Epub 2006 Nov 3. Am J Physiol Heart Circ Physiol. 2007. PMID: 17085540 Free article.

3

Emerging thrombotic effects of drug eluting stents.

Lang NN, Newby DE. Lang NN, et al. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):261-2. doi: 10.1161/01.ATV.0000255308.41576.ae. Arterioscler Thromb Vasc Biol. 2007. PMID: 17229968 No abstract available.

4

Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.

Gudmundsdóttir IJ, Lang NN, Boon NA, Ludlam CA, Webb DJ, Fox KA, Newby DE. Gudmundsdóttir IJ, et al. Among authors: lang nn. J Am Coll Cardiol. 2008 May 6;51(18):1749-56. doi: 10.1016/j.jacc.2007.12.047. J Am Coll Cardiol. 2008. PMID: 18452780 Free article.

5

Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.

Lang NN, Gudmundsdóttir IJ, Boon NA, Ludlam CA, Fox KA, Newby DE. Lang NN, et al. J Am Coll Cardiol. 2008 Jul 1;52(1):33-9. doi: 10.1016/j.jacc.2008.04.003. J Am Coll Cardiol. 2008. PMID: 18582632 Free article.

6

The vascular effects of rotigaptide in vivo in man.

Lang NN, Myles RC, Burton FL, Hall DP, Chin YZ, Boon NA, Newby DE. Lang NN, et al. Biochem Pharmacol. 2008 Nov 15;76(10):1194-200. doi: 10.1016/j.bcp.2008.08.022. Epub 2008 Aug 27. Biochem Pharmacol. 2008. PMID: 18789901 Clinical Trial.

7

Vascular B1 kinin receptors in patients with congestive heart failure.

Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, Newby DE. Lang NN, et al. J Cardiovasc Pharmacol. 2008 Nov;52(5):438-44. doi: 10.1097/FJC.0b013e31818c66cb. J Cardiovasc Pharmacol. 2008. PMID: 19033823 Clinical Trial.

8

Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention.

Mills NL, Tura O, Padfield GJ, Millar C, Lang NN, Stirling D, Ludlam C, Turner ML, Barclay GR, Newby DE. Mills NL, et al. Among authors: lang nn. Heart. 2009 Dec;95(24):2003-8. doi: 10.1136/hrt.2008.163162. Epub 2009 May 28. Heart. 2009. PMID: 19482845

9

Urocortins in heart failure.

Venkatasubramanian S, Newby DE, Lang NN. Venkatasubramanian S, et al. Among authors: lang nn. Biochem Pharmacol. 2010 Aug 1;80(3):289-96. doi: 10.1016/j.bcp.2010.03.032. Epub 2010 Apr 2. Biochem Pharmacol. 2010. PMID: 20363214 Review.

10

Vascular PAR-1: activity and antagonism.

Lang NN, Guðmundsdóttir IJ, Newby DE. Lang NN, et al. Cardiovasc Ther. 2011 Dec;29(6):349-61. doi: 10.1111/j.1755-5922.2010.00140.x. Epub 2010 May 27. Cardiovasc Ther. 2011. PMID: 20528879 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters